Insider transactions

Charles R Kaye

CIK 1239318 · last filed 2020-01-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$1.22B
Companies
16
Total Filings
40
Lifetime Open-Market Net
-$4.02B

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

KOS price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY 10017
Related Filers
Joseph P. Landy — 344 joint filings, latest 2019-12-18
WARBURG PINCUS LLC — 326 joint filings, latest 2020-01-14
WARBURG PINCUS & CO. — 318 joint filings, latest 2020-01-14
Warburg Pincus Partners LLC — 232 joint filings, latest 2014-09-10
Warburg Pincus X, L.P. — 125 joint filings, latest 2020-01-14
Warburg Pincus X GP L.P. — 124 joint filings, latest 2020-01-14
Warburg Pincus Private Equity IX, L.P. — 108 joint filings, latest 2016-05-25
Warburg Pincus X Partners, L.P. — 103 joint filings, latest 2020-01-14
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRWD 10%+ Owner 0 $228.90 $0 -$3.35M 1 2020-01-03
Silk Road Medical Inc (SILK) Delisted 10%+ Owner 8,036,301 $27.49 $220.92M -$164.45M 1 2019-08-12
AR Director 0 $36.25 $0 -$305.61M 2 2019-06-12
AVALARA, INC. (AVLR) Delisted 10%+ Owner 4,859,989 $93.48 $454.31M -$306.35M 2 2019-05-22
KOS Director 49,665,009 $2.06 $102.31M -$1.06B 2 2018-11-28
Vital Energy, Inc. (LPI) Delisted 10%+ Owner 5,792,155 $48.09 $278.54M -$52.95M 5 2018-09-28
Triton International Ltd (TRTN) Delisted Director 7,469,790 $79.55 $594.22M -$64.34M 1 2018-09-07
Endurance International Group Holdings, Inc. (EIGI) Delisted 10%+ Owner 36,669,844 — — -$340.46M 3 2016-08-16
China Biologic Products, Inc. (CBPO) Delisted Director 1,312,200 $119.99 $157.45M -$1.02B 8 2016-06-08
Santander Consumer USA Holdings Inc. (SC) Delisted 10%+ Owner 0 $41.60 $0 -$655.71M 2 2014-09-10
FIS 10%+ Owner 18,993,414 $28.36 $538.75M $0 2 2013-02-15
NATIONAL PENN BANCSHARES INC (NPBC) Delisted Director 25,054,789 — — $2.98M 1 2011-08-22
Polypore International, Inc. (PPO) Delisted 10%+ Owner 15,602,527 — — -$47.89M 4 2011-03-22
BLDR 10%+ Owner 8,768,636 $66.11 $579.74M $366.3K 1 2008-02-29
ZYMOGENETICS INC (ZGEN) Delisted 10%+ Owner 7,401,097 $12.01 $88.89M $2.60M 1 2007-09-13
JARDEN CORP (JAH) Delisted Director 21,044 — — $0 1 2007-05-24

Recent Filings · Page 4 of 4

40 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-12-07 China Biologic Products, Inc. (CBPO) Delisted Buy (P) +100,840 $1.02M EDGAR
2011-12-01 China Biologic Products, Inc. (CBPO) Delisted Buy (P) +43,688 $327.2K EDGAR
2011-08-22 NATIONAL PENN BANCSHARES INC (NPBC) Delisted Buy (P) +472,209 $2.98M EDGAR
2011-03-22 Polypore International, Inc. (PPO) Delisted Other (J) +5,159,775 $0 EDGAR
2010-08-20 Polypore International, Inc. (PPO) Delisted Other (J) −1,775,533 $0 EDGAR
2008-05-30 Polypore International, Inc. (PPO) Delisted Sell (S) −1,995,253 -$47.89M EDGAR
2008-05-27 Polypore International, Inc. (PPO) Delisted Other (J) −5,282,357 $0 EDGAR
2008-02-29 BLDR Buy (P) +53,100 $366.3K EDGAR
2007-09-13 ZYMOGENETICS INC (ZGEN) Delisted Buy (P) +223,783 $2.60M EDGAR
2007-05-24 JARDEN CORP (JAH) Delisted Sell (S) +3,500 $0 EDGAR
Showing 31–40 of 40
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.